Millie
your market intelligence analyst
Search Results
141 results
Your search is now limited to «Bristol-Myers Squibb» expert search.
PharmiWeb.com 07/31/2020 08:30
Pune, Maharashtra, India, July 31 2020 (Wiredrelease) MarketResearch.Biz –: The recent report posted via MarketResearch.Biz on Schizophrenia market offers critical market insights in conjunction with targeted segmentation evaluation. The report examines key using elements which might be anticipated to drive the increase of the market. Global Schizophrenia Market Research Report offers crucial data on numerous market situations, for example, ability improvement elements, elements controlling t...
More from PharmiWeb.com:
Seeking Alpha 07/30/2020 15:52
Bristol Myers Squibb resubmits multiple myeloma therapy application Bristol Myers Squibb (BMY) announced that it has resubmitted its application for ide-cel, a cell therapy targeting blood cancer multiple myeloma.
More from Seeking Alpha:
Benzinga 07/30/2020 08:09
In premarket trading, Bristol-Myers Squibb shares were down 0.76% at $58.70 and Bluebird bio shares were trading 0.58% higher at $62.70.
More from Benzinga:
Business Wire 07/30/2020 06:59
Ms. Price commented, “I am delighted to join the Board of Bristol Myers Squibb at this important moment in its history.
More from Business Wire:
PMLiVE 07/30/2020 06:13
According to BMS/bluebird, the new submission provides further details on the chemistry, manufacturing and controls (CMC) module of the application to address the FDA’s concerns around the original BLA submission.
More from PMLiVE:
Healio News 07/29/2020 17:28
Bristol-Myers Squibb and bluebird bio resubmitted a biologics license application to the FDA for idecabtagene vicleucel — an investigational chimeric antigen receptor T-cell therapy — for the treatment of adults with relapsed or refractory multiple myeloma.
More from Healio News:
Investor's Business Daily 07/20/2020 19:19
In a welcome move, Bristol-Myers Squibb (BMY) saw its Relative Strength Rating improve from 67 to 71 on Monday.
More from Investor's Business Daily:
Motley Fool 07/19/2020 06:35
Assuming you purchased Bristol Myers Squibb shares during this economic downturn, let's see how much your investment would be worth today.
More from Motley Fool:
FiercePharmaManufacturing 07/14/2020 14:49
Vertex hires BMS vet Atkinson to shore up manufacturing for bustling cell and gene therapy pipeline.
More from FiercePharmaManufacturing:
PR Newswire 07/13/2020 07:30
CARY, N.C., July 13, 2020 /PRNewswire/ -- Global biopharmaceutical company Bristol Myers Squibb, based in Princeton, NJ, has earned the prestigious global CEO Cancer Gold Standard™ accreditation for its ongoing commitment to reduce cancer risk for employees and their family members around...
More from PR Newswire:
Forbes 07/09/2020 02:19
That said, we believe Bristol-Myers Squibb will likely fare better than Amgen because of its current valuation, and the recent Celgene acquisition, which has expanded its drugs portfolio and pipeline, while Amgen bets on its new drugs for future growth ...
More from Forbes:
Fortune 07/07/2020 16:06
Bristol Myers, Novartis, and others have shared their libraries of pharmaceutical compounds, or drug formulas, that might help treat the symptoms of the coronavirus.
More from Fortune:
Zacks.com 07/07/2020 13:41
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group ( BABA ), NVIDIA ( NVDA ) and Bristol Myers Squibb ( BMY.
More from Zacks.com:
Xconomy 07/06/2020 09:59
Bristol Myers Squibb likes what it sees from the immune cell research of Dragonfly Therapeutics so far—enough to pay $55 million to add multiple sclerosis and neuroinflammation to their ongoing partnership.
More from Xconomy:
3BL Media 07/01/2020 05:45
John Damonti, President of the Bristol Myers Squibb Foundation, said that the program has been even more successful than expected.
More from 3BL Media:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications